Lack of repeatability of radiomic features derived from PET scans: Results from a 18F-DCFPyL test-retest cohort

被引:6
|
作者
Werner, Rudolf A. [1 ,2 ]
Habacha, Bilel [3 ]
Luetje, Susanne [3 ]
Bundschuh, Lena [4 ]
Kosmala, Alekandser [1 ]
Essler, Markus [3 ]
Derlin, Thorsten [5 ]
Higuchi, Takahiro [1 ]
Lapa, Constantin [4 ]
Buck, Andreas K. [1 ]
Pienta, Kenneth J. [6 ]
Lodge, Martin A. [2 ]
Eisenberger, Mario A. [7 ]
Markowski, Mark C. [7 ]
Pomper, Martin G. [2 ,6 ,7 ]
Gorin, Michael A. [8 ]
Frey, Eric C. [9 ]
Rowe, Steven P. [2 ,6 ,7 ]
Bundschuh, Ralph A. [3 ,4 ]
机构
[1] Univ Hosp Wurzburg, Dept Nucl Med, Wurzburg, Germany
[2] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA
[3] Univ Hosp Bonn, Dept Nucl Med, Bonn, Germany
[4] Univ Augsburg, Med Fac, Nucl Med, Stenglinstr 2, D-86156 Augsburg, Germany
[5] Hannover Med Sch, Dept Nucl Med, Hannover, Germany
[6] Johns Hopkins Univ, Sch Med, Dept Urol, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA
[7] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[8] Icahn Sch Med Mt Sinai, Milton & Carroll Petrie Dept Urol, New York, NY 10029 USA
[9] Radiopharmaceut Imaging & Dosimetry LLC, Baltimore, MD USA
来源
PROSTATE | 2023年 / 83卷 / 06期
基金
美国国家卫生研究院;
关键词
F-18-DCFPyL; prostate cancer; PSMA; radiomics; repeatability; textural features; PROSTATE-CANCER; PSMA-PET; STANDARD;
D O I
10.1002/pros.24483
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesPET-based radiomic metrics are increasingly utilized as predictive image biomarkers. However, the repeatability of radiomic features on PET has not been assessed in a test-retest setting. The prostate-specific membrane antigen-targeted compound F-18-DCFPyL is a high-affinity, high-contrast PET agent that we utilized in a test-retest cohort of men with metastatic prostate cancer (PC). MethodsData of 21 patients enrolled in a prospective clinical trial with histologically proven PC underwent two F-18-DCFPyL PET scans within 7 days, using identical acquisition and reconstruction parameters. Sites of disease were segmented and a set of 29 different radiomic parameters were assessed on both scans. We determined repeatability of quantification by using Pearson's correlations, within-subject coefficient of variation (wCOV), and Bland-Altman analysis. ResultsIn total, 230 lesions (177 bone, 38 lymph nodes, 15 others) were assessed on both scans. For all investigated radiomic features, a broad range of inter-scan correlation was found (r, 0.07-0.95), with acceptable reproducibility for entropy and homogeneity (wCOV, 16.0% and 12.7%, respectively). On Bland-Altman analysis, no systematic increase or decrease between the scans was observed for either parameter (+/- 1.96 SD: 1.07/-1.30, 0.23/-0.18, respectively). The remaining 27 tested radiomic metrics, however, achieved unacceptable high wCOV (>= 21.7%). ConclusionMany common radiomic features derived from a test-retest PET study had poor repeatability. Only Entropy and homogeneity achieved good repeatability, supporting the notion that those image biomarkers may be incorporated in future clinical trials. Those radiomic features based on high frequency aspects of images appear to lack the repeatability on PET to justify further study.
引用
收藏
页码:547 / 554
页数:8
相关论文
共 50 条
  • [1] Test-Retest Reproducibility of Radiomic Features on PSMA-targeted 18F-DCFPyL PET/CT in Patients with Metastatic Prostate Cancer
    Werner, Rudolf
    Habacha, Bilel
    Bundschuh, Lena
    Higuchi, Takahiro
    Serfling, Sebastian
    Derlin, Thorsten
    Essler, Markus
    Lapa, Constantin
    Pienta, Kenneth
    Buck, Andreas
    Eisenberger, Mario
    Markowski, Mark
    Lodge, Martin
    Pomper, Martin
    Gorin, Michael
    Rowe, Steven
    Bundschuh, Ralph
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [2] High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL
    Werner, Rudolf A.
    Habacha, Bilel
    Luetje, Susanne
    Bundschuh, Lena
    Higuchi, Takahiro
    Hartrampf, Philipp
    Serfling, Sebastian E.
    Derlin, Thorsten
    Lapa, Constantin
    Buck, Andreas K.
    Essler, Markus
    Pienta, Kenneth J.
    Eisenberger, Mario A.
    Markowski, Mark C.
    Shinehouse, Laura
    AbdAllah, Rehab
    Salavati, Ali
    Lodge, Martin A.
    Pomper, Martin G.
    Gorin, Michael A.
    Bundschuh, Ralph A.
    Rowe, Steven P.
    MOLECULAR IMAGING, 2022, 2022
  • [3] Test-retest repeatability of organ uptake on PSMA-targeted 18F-DCFPyL PET/CT in patients with prostate cancer
    Werner, Rudolf A.
    Luetje, Susanne
    Habacha, Bilel
    Bundschuh, Lena
    Higuchi, Takahiro
    Buck, Andreas K.
    Kosmala, Aleksander
    Lapa, Constantin
    Essler, Markus
    Lodge, Martin A.
    Pienta, Kenneth J.
    Eisenberger, Mario A.
    Markowski, Mark C.
    Gorin, Michael A.
    Pomper, Martin G.
    Rowe, Steven P.
    Bundschuh, Ralph A.
    PROSTATE, 2023, 83 (12): : 1186 - 1192
  • [4] Reproducibility and Reliability of Radiomic Features in 18F-DCFPyL PET/CT Imaging of Prostate Cancer
    Ashrafinia, Saeed
    DiGianvittorio, Michael
    Rowe, Steven
    Gorin, Michael
    Lu, Lijun
    Lodge, Martin
    Pomper, Martin
    Allaf, Mohamad
    Rahmim, Arman
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [5] Test-Retest Repeatability of 18F-FET PET in Small Volumes
    Ferjancic, P.
    Ebert, M. A.
    Nowak, A. K.
    Francis, R. J.
    Jeraj, R.
    MEDICAL PHYSICS, 2019, 46 (06) : E398 - E398
  • [6] Test-Retest Reproducibility of Conventional Quantitative Parameters on PSMA-targeted 18F-DCFPyL PET/CT in Patients with Metastatic Prostate Cancer
    Werner, Rudolf
    Habacha, Bilel
    Bundschuh, Lena
    Higuchi, Takahiro
    Hartrampf, Philipp
    Widjaja, Liam
    Derlin, Thorsten
    Buck, Andreas
    Essler, Markus
    Pienta, Kenneth
    Eisenberger, Mario
    Markowski, Mark
    Lodge, Martin
    Pomper, Martin
    Gorin, Michael
    Bundschuh, Ralph
    Rowe, Steven
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [7] [18F]FNDP PET neuroimaging test-retest repeatability and whole-body dosimetry in humans
    Du, Yong
    Coughlin, Jennifer M.
    Amindarolzarbi, Alireza
    Sweeney, Shannon Eileen
    Harrington, Courtney K.
    Brosnan, Mary Katherine
    Zandi, Adeline
    Shinehouse, Laura K.
    Sanchez, Alejandra N. Reyes
    Abdallah, Rehab
    Holt, Daniel P.
    Fan, Hong
    Lesniak, Wojciech G.
    Nandi, Ayon
    Rowe, Steven P.
    Solnes, Lilja B.
    Dannals, Robert F.
    Horti, Andrew G.
    Lodge, Martin A.
    Pomper, Martin G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (12) : 3659 - 3665
  • [8] Test-retest repeatability of [18F]Flortaucipir PET in Alzheimer's disease and cognitively normal individuals
    Timmers, Tessa
    Ossenkoppele, Rik
    Visser, Denise
    Tuncel, Hayel
    Wolters, Emma E.
    Verfaillie, Sander C. J.
    van der Flier, Wiesje M.
    Boellaard, Ronald
    Golla, Sandeep S., V
    van Berckel, Bart N. M.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2020, 40 (12): : 2464 - 2474
  • [9] Test-retest repeatability of myocardial radiomic features from quantitative cardiac magnetic resonance T1 and T2 mapping
    Marfisi, Daniela
    Giannelli, Marco
    Marzi, Chiara
    Del Meglio, Jacopo
    Barucci, Andrea
    Masturzo, Luigi
    Vignali, Claudio
    Mascalchi, Mario
    Traino, Antonio
    Casolo, Giancarlo
    Diciotti, Stefano
    Tessa, Carlo
    MAGNETIC RESONANCE IMAGING, 2024, 113
  • [10] Assessment of variability of 18F-DCFPyL PSMA PET/CT and PET/MR quantitative parameters from reference standard organs
    Lawrence, Edward
    Kieler, Minnie
    Cooley, Greg
    Wells, Shane
    Cho, Steve
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61